RecruitingNCT07335341

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Sponsor

Medtronic Endovascular

Enrollment

50 participants

Start Date

Feb 24, 2026

Study Type

OBSERVATIONAL

Conditions

Peripheral Arterial Disease DVT Acute Limb Ischemia Thrombus in the Peripheral Venous Vasculature Lower Extremity Acute Limb Ischemia LE ALI Venous Embolism of Lower Extremities (Diagnosis)Arterial Embolism and Thrombosis Acute DVT of Lower Extremity Chronic DVT of Lower Extremity Deep Vein Thrombosis Leg

Summary

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Liberant Thrombectomy System for people with acute dvt of lower extremity, acute limb ischemia, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELiberant Thrombectomy System

The Liberant thrombectomy system is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems